Clinical Trial Update: Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing the efficacy, safety, and immunogenicity of GSK's Herpes Zoster vaccine in adults aged 70 and older; study completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• GSK1437173A (GSK1437173A)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Herpes Zoster, Herpes Zoster Vaccine | Phase 3 | Status: COMPLETED | Results posted: 2017-11-20